Neumora Therapeutics Inc (NMRA) Directors and Executive Officers - CSIMarket
CSIMarket
 
Neumora Therapeutics Inc   (NASDAQ: NMRA)

Neumora Therapeutics Inc

Officers & Directors


Henry O. Gosebruch
Chief Executive Officer

Kristina Burow
Director

Maykin Ho, Ph.D
Director

Matthew K. Fust
Director

Joshua Pinto, Ph.D
Chief Financial Officer

David Piacquad
Director

Michael Milligan
Principal Accounting Officer

Alaa Halawa
Director

Paul L. Berns
Director ,

Neumora Therapeutics Inc currently has 96 employees.

  News about Neumora Therapeutics Inc Key Personnel

Neumora Therapeutics Announces Leadership Transition Amid Financial Challenges and Legal Pressures

Neumora Therapeutics Inc. a biopharmaceutical company focused on transforming the treatment landscape for neurological diseases, has recently garnered attention following a significant leadership transition. Paul L. Berns, currently serving as executive chair of the Neumora Board of Directors, will step into the role of chief executive officer (CEO) and chairman of the Board. This transition comes at a critical time for the company, as it navigates through various financial hurdles and legal matters.Leadership Changes and Future DirectionThe appointment of Berns as CEO is expected to bring a new strategic approach to Neumora. With an extensive background in the biotech industry, Berns has held leadership pos...






NMRA Management Effectiveness NMRA Revenue per Employee NMRA Income per Employee


Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.